Addressing tumor blood vessels

被引：77

作者：

Folkman, J

机构：

[1] Harvard Medical School, Children’s Hospital Hunnewell 103, Boston, MA, 02115

来源：

NATURE BIOTECHNOLOGY | 1997年 / 15卷 / 06期

关键词：

D O I：

10.1038/nbt0697-510

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

收藏

页码：510 / 510

页数：1

相关论文

共 11 条

[1] Belotti D, 1996, CLIN CANCER RES, V2, P1843
[2] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
BROOKS, PC
MONTGOMERY, AMP
ROSENFELD, M
REISFELD, RA
HU, TH
KLIER, G
CHERESH, DA
[J]. CELL, 1994, 79 (07) : 1157 - 1164
[3] VASCULAR ATTACK AS A THERAPEUTIC STRATEGY FOR CANCER
DENEKAMP, J
[J]. CANCER AND METASTASIS REVIEWS, 1990, 9 (03) : 267 - 282
[4] ESSERMAN L, 1996, P AM SOC CLIN ONCOL, V15, P129
[5] Clinical significance of the determination of angiogenesis in human breast cancer: Update of the biological background and overview of the Vicenza studies
Gasparini, G
[J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) : 2485 - 2493
[6] Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
Huang, XM
Molema, G
King, S
Watkins, L
Edgington, TS
Thorpe, PE
[J]. SCIENCE, 1997, 275 (5299) : 547 - 550
[7] INGTER DE, 1997, CANC THERAPEUTICS EX
[8] INHIBITION OF TUMOR ANGIOGENESIS AS A STRATEGY TO CIRCUMVENT ACQUIRED-RESISTANCE TO ANTICANCER THERAPEUTIC AGENTS
KERBEL, RS
[J]. BIOESSAYS, 1991, 13 (01) : 31 - 36
[9] Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
OReilly, MS
Boehm, T
Shing, Y
Fukai, N
Vasios, G
Lane, WS
Flynn, E
Birkhead, JR
Olsen, BR
Folkman, J
[J]. CELL, 1997, 88 (02) : 277 - 285
[10] alpha v Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R
Koivunen, E
Ruoslahti, E
[J]. NATURE BIOTECHNOLOGY, 1997, 15 (06) : 542 - 546